A novel monoclonal antibody for RAGE-directed imaging identifies accelerated atherosclerosis in diabetes
- PMID: 20008983
- DOI: 10.2967/jnumed.109.064659
A novel monoclonal antibody for RAGE-directed imaging identifies accelerated atherosclerosis in diabetes
Abstract
Receptor for advanced glycation end products (RAGE) binds advanced glycation end products and other inflammatory ligands and is expressed in atherosclerotic plaques in diabetic and nondiabetic subjects. The higher expression in diabetes mellitus corresponds to the accelerated course of the atherosclerosis. This study was designed to test the hypothesis that the level of RAGE expression in atherosclerosis can be detected by quantitative in vivo SPECT and that counts in the target will correlate with the strength of the biologic signal.
Methods: A monoclonal murine antibody was developed against the V-domain of RAGE, fragmented into F(ab')(2) and labeled with (99m)Tc, and injected at a dose of 15.14 +/- 1.23 MBq into 24-wk-old male apolipoprotein E null (ApoE(-/-)) mice (n = 22), including mice with streptozotocin-induced diabetes mellitus (n = 8), nondiabetic mice (n = 8), and control ApoE(-/-)/RAGE(-/-) double-knock-out mice (n = 6). Four hours later (allowing for blood-pool clearance), the mice were imaged and sacrificed, and the proximal aorta was removed and counted to calculate the percentage injected dose of RAGE per gram of tissue, followed by histologic and immunohistochemical characterization.
Results: Radiotracer uptake in the aortic lesions was clearly visualized noninvasively by SPECT. RAGE uptake as percentage injected dose in diabetic ApoE(-/-) mice (1.39 +/- 0.16 x 10(-2)) was significantly higher than that in nondiabetic ApoE(-/-) mice (0.48 +/- 0.27 x 10(-2)) (P < 0.0001). The radiotracer uptake was highly correlated with RAGE expression by quantitative immunohistomorphometry (r = 0.82, P = 0.002) and with percentage of macrophages (r = 0.86, P < 0.0001).
Conclusion: In this study, (99m)Tc-labeled anti-RAGE F(ab')(2) SPECT successfully identified early accelerated disease in diabetes mellitus for age-matched ApoE(-/-) mice and quantified RAGE expression over a range of lesion severities.
Similar articles
-
Development of receptor for advanced glycation end products-directed imaging of atherosclerotic plaque in a murine model of spontaneous atherosclerosis.Circ Cardiovasc Imaging. 2008 Nov;1(3):212-9. doi: 10.1161/CIRCIMAGING.108.788299. Circ Cardiovasc Imaging. 2008. PMID: 19808545
-
99mTc-Labeled anti-receptor for advanced glycation endproducts monoclonal antibody F(ab’)2 fragments.2010 Jul 16 [updated 2010 Aug 16]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. 2010 Jul 16 [updated 2010 Aug 16]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. PMID: 20734503 Free Books & Documents. Review.
-
Imaging of receptors for advanced glycation end products in experimental myocardial ischemia and reperfusion injury.JACC Cardiovasc Imaging. 2012 Jan;5(1):59-67. doi: 10.1016/j.jcmg.2011.09.016. JACC Cardiovasc Imaging. 2012. PMID: 22239894 Free PMC article.
-
99mTc-Labeled anti-receptor for advanced glycation endproducts polyclonal antibody F(ab’)2 fragments.2010 Jul 16 [updated 2010 Aug 16]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. 2010 Jul 16 [updated 2010 Aug 16]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. PMID: 20734504 Free Books & Documents. Review.
-
Activation of the ROCK1 branch of the transforming growth factor-beta pathway contributes to RAGE-dependent acceleration of atherosclerosis in diabetic ApoE-null mice.Circ Res. 2010 Apr 2;106(6):1040-51. doi: 10.1161/CIRCRESAHA.109.201103. Epub 2010 Feb 4. Circ Res. 2010. PMID: 20133903 Free PMC article.
Cited by
-
Advanced glycation end-product expression is upregulated in the gastrointestinal tract of type 2 diabetic rats.World J Diabetes. 2015 May 15;6(4):662-72. doi: 10.4239/wjd.v6.i4.662. World J Diabetes. 2015. PMID: 25987965 Free PMC article.
-
Imaging RAGE expression in atherosclerotic plaques in hyperlipidemic pigs.EJNMMI Res. 2014 Jun 11;4:26. doi: 10.1186/s13550-014-0026-6. eCollection 2014. EJNMMI Res. 2014. PMID: 25006545 Free PMC article.
-
Synthesis and Evaluation of [(18)F]RAGER: A First Generation Small-Molecule PET Radioligand Targeting the Receptor for Advanced Glycation Endproducts.ACS Chem Neurosci. 2016 Mar 16;7(3):391-8. doi: 10.1021/acschemneuro.5b00319. Epub 2016 Feb 1. ACS Chem Neurosci. 2016. PMID: 26771209 Free PMC article.
-
Imaging receptor for advanced glycation end product expression in mouse model of hind limb ischemia.EJNMMI Res. 2013 May 11;3(1):37. doi: 10.1186/2191-219X-3-37. EJNMMI Res. 2013. PMID: 23663412 Free PMC article.
-
Inflammation Meets Metabolism: Roles for the Receptor for Advanced Glycation End Products Axis in Cardiovascular Disease.Immunometabolism. 2021;3(3):e210024. doi: 10.20900/immunometab20210024. Epub 2021 Jun 2. Immunometabolism. 2021. PMID: 34178389 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous